The clinical efficacy and safety of dapagliflozin in patients with diabetic nephropathy
Abstract Objective To investigate the clinical efficacy and safety of dapagliflozin in the treatment of diabetic nephropathy (DN). Methods A total of 120 DN patients admitted to our hospital from June 2017 to March 2020 were divided into control and experimental groups, with 60 cases in each group....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-03-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-022-00815-y |